New directions in targeting protein kinases: focusing upon true allosteric and bivalent inhibitors.
Curr Pharm Des. 2012;18(20):2936-45. doi: 10.2174/138161212800672813.
Curr Pharm Des. 2012.
PMID: 22571662
Review.